RECENT CHANGES IN INFECTIOUS DISEASES IN EUROPEAN WILDLIFE.

Emerging disease Europe epidemiology human health livestock health pathogen wildlife health

Journal

Journal of wildlife diseases
ISSN: 1943-3700
Titre abrégé: J Wildl Dis
Pays: United States
ID NLM: 0244160

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 5 10 2018
medline: 8 2 2020
entrez: 5 10 2018
Statut: ppublish

Résumé

Many infectious diseases originating from, or carried by, wildlife affect wildlife conservation and biodiversity, livestock health, or human health. We provide an update on changes in the epidemiology of 25 selected infectious, wildlife-related diseases in Europe (from 2010-16) that had an impact, or may have a future impact, on the health of wildlife, livestock, and humans. These pathogens were selected based on their: 1) identification in recent Europe-wide projects as important surveillance targets, 2) inclusion in European Union legislation as pathogens requiring obligatory surveillance, 3) presence in recent literature on wildlife-related diseases in Europe since 2010, 4) inclusion in key pathogen lists released by the Office International des Epizooties, 5) identification in conference presentations and informal discussions on a group email list by a European network of wildlife disease scientists from the European Wildlife Disease Association, or 6) identification as pathogens with changes in their epidemiology during 2010-16. The wildlife pathogens or diseases included in this review are: avian influenza virus, seal influenza virus, lagoviruses, rabies virus, bat lyssaviruses, filoviruses, canine distemper virus, morbilliviruses in aquatic mammals, bluetongue virus, West Nile virus, hantaviruses, Schmallenberg virus, Crimean-Congo hemorrhagic fever virus, African swine fever virus, amphibian ranavirus, hepatitis E virus, bovine tuberculosis ( Mycobacterium bovis), tularemia ( Francisella tularensis), brucellosis ( Brucella spp.), salmonellosis ( Salmonella spp.), Coxiella burnetii, chytridiomycosis, Echinococcus multilocularis, Leishmania infantum, and chronic wasting disease. Further work is needed to identify all of the key drivers of disease change and emergence, as they appear to be influencing the incidence and spread of these pathogens in Europe. We present a summary of these recent changes during 2010-16 to discuss possible commonalities and drivers of disease change and to identify directions for future work on wildlife-related diseases in Europe. Many of the pathogens are entering Europe from other continents while others are expanding their ranges inside and beyond Europe. Surveillance for these wildlife-related diseases at a continental scale is therefore important for planet-wide assessment, awareness of, and preparedness for the risks they may pose to wildlife, domestic animal, and human health.

Identifiants

pubmed: 30284963
pii: 10.7589/2017-07-172
doi: 10.7589/2017-07-172
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-43

Auteurs

Lisa Yon (L)

1 School of Veterinary Medicine and Science, Faculty of Medical and Health Sciences, The University of Nottingham, Sutton Bonington, Leicestershire LE12 5RD, UK.

J Paul Duff (JP)

2 Animal and Plant Health Agency Diseases of Wildlife Scheme (APHA DoWS), Penrith, Cumbria CA11 9RR, UK.

Erik O Ågren (EO)

3 National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.

Károly Erdélyi (K)

4 Veterinary Diagnostic Directorate - National Food Chain Safety Office, Tabornok u.2, 1143, Budapest, Hungary.

Ezio Ferroglio (E)

5 University of Turin, Largo Paolo Braccini, 2 (già Via L. DaVinci, 44)- 10095 Grugliasco (TO), Torino, Italy.

Jacques Godfroid (J)

6 University of Tromsø - the Arctic University of Norway, PO Box 6050 Langnes, 9037 Tromsø, Norway.

Jean Hars (J)

7 Office National de la Chasse et de la Faune Sauvage (ONCFS), 5 all Bethleem, 38610 Gieres, France.

Gete Hestvik (G)

3 National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.

Daniel Horton (D)

8 University of Surrey, 388 Stag Hill, Guildford GU2 7XH, UK.

Thijs Kuiken (T)

9 Erasmus University Medical Centre, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands.

Antonio Lavazza (A)

10 Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (I.Z.S.L.E.R.), Via Antonio Bianchi 7/9, 25124 Brescia, Italy.

Iwona Markowska-Daniel (I)

11 Warsaw University of Life Sciences, ul. 159c Noworsynowska Str., 02776 Warsaw, Poland.

An Martel (A)

12 Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.

Aleksija Neimanis (A)

3 National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.

Frank Pasmans (F)

12 Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.

Stephen J Price (SJ)

13 UCL Genetics Institute, Gower Street, London WC1E 6BT, UK.

Francisco Ruiz-Fons (F)

14 Spanish Wildlife Research Institute IREC, Ronda de Toledo s/n 13005, Ciudad Real, Spain.

Marie-Pierre Ryser-Degiorgis (MP)

15 Centre for Fish and Wildlife Health, Vetsuisse Faculty, University of Bern, Langgass-str. 122, 3001 Bern, Switzerland.
16 OIE (Office International des Epizooties) Working Group on Wildlife.

Frederik Widén (F)

3 National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.

Dolores Gavier-Widén (D)

3 National Veterinary Institute (SVA), Ulls väg 2B, SE75189 Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH